To evaluate the efficacy and safety of AST-120 in a Western population , a phase 3 , multicenter , randomized , double-blind , placebo-controlled , study ( FHAST-1 ) was conducted in adult patients with at least 1 draining perianal fistula and a Crohn 's disease activity index < 400 .